Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2025 | Making alloSCT safer for patients: the value of graft engineering techniques

Rawan Faramand, MD, Moffitt Cancer Center, Tampa, FL, highlights advances made in allogeneic stem cell transplantation (alloSCT) for patients with hematological malignancies, emphasizing the value of using graft engineering techniques to make alloSCT safer. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.